Fortis Healthworld, a Religare Group company, will acquire pharmacy retail chain CRS Health, a Delhi-based pharmaceutical and wellness retail chain for Rs 15 crore. Under the deal, Fortis HealthWorld will acquire all 27 retail stores and four warehouses of CRS Health in India. CRS Health has significant presence in South and West India.
The Sun Pharma is all set to buy Israel-drug maker Taro. The US Federal Trade Commission (FTC) has given its approval for the deal on certain conditions. The Mumbai-based drug maker Sun has to sell rights and assets of its anti-epilepsy drugs. Carbamazepine is a major anti-epilepsy brand prepared buy sun group. The Sun Pharma is ready to sell three distinct generic formulations to Torrent Pharmaceutical Ltd. Torrent Pharmaceutical Ltd is a major drug maker of Gujrat.
‘Easy Five’, is a vaccine, which combats five infections diseases of early childhood.
Biotechnology firm Panacea Biotec has secured Rs 143 crore-contract from the United Nations Children’s Fund (UNICEF) for supplying this vaccine.
Panacea Biotec is the first Indian pharmaceutical company to get this order from UNICEF for its vaccines in fully liquid form, the company informed the Bombay Stock Exchange.
The order starts in 2008 and would continue till 2009.
Fortis Healthworld, a Religare Group company, will acquire pharmacy retail chain CRS Health, a Delhi-based pharmaceutical and wellness retail chain for Rs 15 crore. Under the deal, Fortis HealthWorld will acquire all 27 retail stores and four warehouses of CRS Health in India. CRS Health has significant presence in South and West India.
Pharmaceutica
Commission (FTC) has given its approval for the deal on certain conditions. The Mumbai-based drug maker Sun has to sell rights and assets of its anti-epilepsy drugs. Carbamazepine is a major anti-epilepsy brand prepared buy sun group. The Sun Pharma is ready to sell three distinct generic formulations to Torrent Pharmaceutical Ltd. Torrent Pharmaceutical Ltd is a major drug maker of Gujrat. 
